Stocks › Diagnostics & Research › FLGT

Fulgent Genetics FLGT

US equityMarket cap rank #3662Diagnostics & Research

$20.57 −$0.01 (-0.05%)

Pre-market · Oct 8, 8:40 am ET · After hours $20.57 0.00%

Open$20.48

Prev close$20.58

Day range$19.90 – $20.70

Volume298.3K

Market cap$565.99M

P/E (TTM)–

Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership57.8%-0.03 pts vs. prior quarter

Institutions holding180+0 vs. prior quarter

Insider trades (recent)12 buys / 38 sellsNet selling

Short interest8.42% of floatDays to cover 6.7 · as of 15 Sep 2026

Short-sale volume share17.0%5-day average of daily volume

Short-sale volume as % of daily volume

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$61.8K (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 51.2% of shares outstanding.

Largest holders

Ming Hsieh32.25%
BlackRock8.31%
Acadian Asset Management LLC3.70%
Hanlin Gao3.58%
Vanguard Capital Management, LLC3.33%
Jacobs Levy Equity Management Inc2.84%
JPMorgan Chase & Co.2.61%
Diametric Capital, LP2.54%

By investor type

Mutual Fund39.97%
Individual/Insider39.34%
Hedge Fund10.40%
Public Company4.88%
Private Company1.25%
Family Office/Trust0.87%
Government Pension Fund0.25%
Insurance Company0.15%

Reported short interest has fallen from 9.25% to 8.42% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

Holder	Type	Period	Share change	New stake
Jacobs Levy Equity Management Inc	Mutual Fund	2026/Q3	+425,757	2.8%
Diametric Capital, LP	Hedge Fund	2026/Q3	+336,738	2.5%
JPMorgan Chase & Co.	Public Company	2026/Q3	+298,416	2.6%
Point72 Asset Management, L.P.	Hedge Fund	2026/Q3	+211,708	0.8%
Hudson River Trading LLC	Private Company	2026/Q3	+182,996	0.8%
Citadel Advisors LLC	Hedge Fund	2026/Q3	+121,232	0.6%
Columbia Management Investment Advisers, LLC	Mutual Fund	2026/Q3	+106,709	2.4%
Goldman Sachs Asset Management, L.P.	Mutual Fund	2026/Q3	+103,892	0.5%
Two Sigma Investments, LP	Hedge Fund	2026/Q3	+78,797	1.5%
Levin Capital Strategies, L.P.	Mutual Fund	2026/Q3	+62,308	0.4%
Caxton Associates (USA) LLC	Hedge Fund	2026/Q3	+62,069	0.2%
Balyasny Asset Management L.P.	Hedge Fund	2026/Q3	+55,078	0.2%
Bank of America Corporation	Public Company	2026/Q3	+54,998	0.6%
ExodusPoint Capital Management, LP	Hedge Fund	2026/Q3	+47,087	0.2%
Brevan Howard Capital Management LP	Mutual Fund	2026/Q3	+44,812	0.2%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

Date	Insider	Title	Transaction	Shares	Price	Held after
1 Sep 2026	Hanlin Gao	Chief Scientific Officer & Laboratory Director	Open Market Disposition	-1,673	$19.66	986,117
1 Sep 2026	Jian Xie	Chief Operating Officer	Open Market Disposition	-2,127	$19.66	580,740
31 Aug 2026	Paul Kim	Chief Financial Officer	Sale to Issuer	-2,087	$19.59	356,543
31 Aug 2026	Ming Hsieh	Chairperson & CEO	Sale to Issuer	-4,392	$19.59	8,874,487
26 Aug 2026	Hanlin Gao	Chief Scientific Officer & Laboratory Director	Open Market Disposition	-939	$19.91	987,790
26 Aug 2026	Jian Xie	Chief Operating Officer	Open Market Disposition	-1,193	$19.91	582,867
25 Aug 2026	Paul Kim	Chief Financial Officer	Sale to Issuer	-1,168	$19.81	358,630
25 Aug 2026	Ming Hsieh	Chairperson & CEO	Sale to Issuer	-2,949	$19.81	8,870,694
25 Jul 2026	Paul Kim	Chief Financial Officer	Sale to Issuer	-2,747	$19.67	359,798
25 Jul 2026	Hanlin Gao	Chief Scientific Officer & Laboratory Director	Sale to Issuer	-1,645	$19.67	988,729
25 Jul 2026	Jian Xie	Chief Operating Officer	Sale to Issuer	-4,361	$19.67	584,060
1 Jun 2026	Hanlin Gao	Chief Scientific Officer & Laboratory Director	Open Market Disposition	-1,688	$17.89	990,374
1 Jun 2026	Jian Xie	Chief Operating Officer	Open Market Disposition	-2,146	$17.89	588,421
31 May 2026	Paul Kim	Chief Financial Officer	Sale to Issuer	-2,087	$18.09	362,545
31 May 2026	Ming Hsieh	Chairperson & CEO	Sale to Issuer	-4,392	$18.09	8,868,147
26 May 2026	Hanlin Gao	Chief Scientific Officer & Laboratory Director	Open Market Disposition	-945	$17.60	992,062
26 May 2026	Jian Xie	Chief Operating Officer	Open Market Disposition	-1,201	$17.60	590,567
25 May 2026	Paul Kim	Chief Financial Officer	Sale to Issuer	-1,168	$17.67	364,632
25 May 2026	Ming Hsieh	Chairperson & CEO	Sale to Issuer	-2,949	$17.67	8,864,354
13 May 2026	Regina Groves	Independent Director	Other Acquisition	+11,117	–	23,099

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report date	Shares short	% of float	Days to cover
15 Sep 2026	2,318,058	8.4%	6.7
31 Aug 2026	2,368,385	8.6%	10.0
14 Aug 2026	2,555,609	9.3%	9.3
31 Jul 2026	2,565,192	9.3%	8.0
15 Jul 2026	2,753,798	9.7%	11.4
30 Jun 2026	2,627,189	9.3%	7.9

Discussion

No comments yet — be the first to weigh in on FLGT.